Evidence-based treatment for gynoid lipodystrophy: A review of the recent literature.
J Cosmet Dermatol
; 17(6): 977-983, 2018 Dec.
Article
em En
| MEDLINE
| ID: mdl-29707877
ABSTRACT
Gynoid lipodystrophy (GLD) is a structural, inflammatory, and biochemical disorder of the subcutaneous tissue causing alterations in the topography of the skin. Commonly known as "cellulite," GLD affects up to 90% of women, practically in all stages of the life cycle, beginning in puberty. It is a clinical condition that considerably affects the patients' quality of life. It is a frequent reason for consultation, although the patients resort to empirical, improvised, nonevidence-based treatments which discourage and can be a source of frustration not only because of the lack of results but also due to the complications derived from those treatments. In this article, a panel of experts from different specialties involved in the management of this clinical skin disorder presents the results of a systematic literature search and of the consensus discussion of the evidence obtained from different treatments currently available. The analysis was divided into topical, systemic, noninvasive, and minimally invasive treatments.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Métodos Terapêuticos e Terapias MTCI:
Terapias_biologicas
/
Terapias_manuales
/
Masoterapia
Assunto principal:
Preparações Farmacêuticas
/
Celulite
Idioma:
En
Revista:
J Cosmet Dermatol
Ano de publicação:
2018
Tipo de documento:
Article
País de afiliação:
México